Browse current and past press releases from The Michael J. Fox Foundation.
Ultra-Athlete Sam Fox and More Than 2,000 People Complete ďTour de FoxĒ Journey to Raise Nearly $2 Million for The Michael J. Fox Foundation
September 17, 2015
After three grueling months of hiking, climbing and biking across the contiguous United States, ultra-athlete and Michael J. Fox Foundation staffer Sam Fox (no relation to Michael J. Fox) completed Tour de Fox (tourdefox.org) in Vancouver, British Columbia, Canada, on Saturday, September 12. The Tour, which set out from Maine on June 2, generated nearly double its $1-million goal, ultimately raising $1.87 million (and counting) for Parkinson's research.
Sam's odyssey covered a total of 14,000 m...Read More
The Michael J. Fox Foundation and The Michael Stern Parkinson's Research Foundation Join Forces to Accelerate Novel Ideas in Parkinson's Research
June 30, 2015
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Michael Stern Parkinson's Research Foundation (MSPRF) announced today the merging of their organizations to advance cutting-edge research focused on the underlying cause, diagnosis and treatment of Parkinson's disease (PD). The partnership creates the Michael Stern Discovery Grants in Parkinson's Science to support high-risk discovery work as the backbone of drug development.
"For nearly 15 years, The Michael Stern Parkinson'...Read More
Ultra-Athlete Sam Fox Embarks on 14,000-mile Cross-Country "Tour de Fox" to Raise $1 Million for Michael J. Fox Foundation
June 02, 2015
Today, ultra-athlete and Michael J. Fox Foundation staffer Sam Fox (no relation to Michael J. Fox) kicks off Tour de Fox (www.tourdefox.org). With a name inspired by the legendary 2500-kilometer bike race across France that annually challenges the grit and endurance of the world's greatest cyclists, Tour de Fox is a 14,000-mile biking and hiking adventure across the contiguous United States into British Columbia, Canada.
Sam, 27, will test his physical limits, biking more than 5,000 miles en ro...Read More
The Michael J. Fox Foundation Announces Five Academic Centers Chosen for 2016 Edmond J. Safra Fellowships in Movement Disorders
May 18, 2015
The Michael J. Fox Foundation for Parkinson's Research, in collaboration with its longtime supporter and partner The Edmond J. Safra Foundation, has selected four academic centers in the United States and one in Canada to host the inaugural class of the Edmond J. Safra Fellowship in Movement Disorders.
The five centers selected for the 2016-2018 Edmond J. Safra Fellowship in Movement Disorders class are:
- Columbia University Medical Center in New York
- Emory University in Atlanta
The Michael J. Fox Foundation for Parkinson's Research Confers Inaugural Bachmann-Strauss Prize for Excellence in Dystonia Research
May 13, 2015
At an event celebrating the new collaborative research alliance between The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Bachmann-Strauss Dystonia and Parkinson Foundation (BSDPF), MJFF tonight confers the inaugural Bachmann-Strauss Prize for Excellence in Dystonia Research on Xandra O. Breakefield, PhD, professor of neurology at Harvard Medical School and geneticist at Massachusetts General Hospital, for groundbreaking discoveries in the field of dystonia genetics.
The gal...Read More
The Michael J. Fox Foundation and Imago Pharmaceuticals Partner to Advance Use of Research Tools to Speed Parkinsonís Research
May 11, 2015
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.
Imago purchased the tools as part of a deal with health firm Perrigo in late 2014. These parkin assets originated at now-defunct biotech El...Read More
The Michael J. Fox Foundation and Prothena Partner to Accelerate Discovery of Novel Biomarkers for Parkinsonís Disease
May 04, 2015
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapy programs, today announced an agreement under which they will seek to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson's disease progression. The joint initiative will focus on biomarkers that may facilitate therapeut...Read More
John Hardy, PhD, Leader in Parkinsonís Genetics Research, Honored with 2015 Robert A. Pritzker Prize
April 15, 2015
John Hardy, PhD, a pioneer in the study of Parkinson's genetics, is the recipient of the 2015 Robert A. Pritzker Prize for Leadership in Parkinson's Research, conferred annually by The Michael J. Fox Foundation for Parkinson's Research (MJFF).
An expert in Alzheimer's genetics, as well, Hardy — now professor at UCL (University College London) — led a team toward a pathological discovery that revolutionized Parkinson's drug development. Moreover, he is regarded as an influential thought leader i...Read More
March 24, 2015
NEW YORK — The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation for Parkinson's Research (MJFF), is expanding to study individuals with a mutation of the GBA (glucosidase beta acid) gene. Participants will include people with or at increased risk to develop Parkinson's disease. Researchers hope that a greater understanding of the biology and clinical features of these participants will lead to therapies benefiting all Pa...Read More
Sage Bionetworks and The Michael J. Fox Foundation Collaborate to Amplify Parkinsonís Patient Voice in Research
March 09, 2015
- Parkinson mPower iPhone app-based clinical study provides intuitive platform for empowering research participants as partners to illuminate Parkinson's disease symptom variation
- mPower uses ResearchKit, a new software framework announced today by Apple that turns iPhone into a powerful tool for medical research
- Fox Insight virtual clinical study offers every Parkinson's patient the opportunity to securely contribute data to speed the cure
Sage Bionetworks, a nonprofit biomedical research ...Read More
Leading Research Funders Build On Global Initiative With New Nearly $2 Million Commitment To Study Commonalities Of Neurodegenerative Diseases
March 05, 2015
Together, leading funders of research in the U.S., Canada and U.K. are advancing a global funding initiative aimed at better understanding the similarities and differences between progressive brain-deteriorating diseases, such as Alzheimer's and Parkinson's, with an expanded partnership and increased funding.
The program, Biomarkers Across Neurodegenerative Diseases (BAND), is a joint initiative of the Alzheimer's Association and The Michael J. Fox Foundation for Parkinson's Research in the U.S...Read More
Michael J. Fox Foundation Analysis Reveals Gaps between Research Volunteers and Parkinsonís Clinical Studies
February 23, 2015
Baseline paper highlights findings from Fox Trial Finder, first smart-matching clinical research recruitment tool for Parkinson's disease
A paper authored by The Michael J. Fox Foundation for Parkinson's Research (MJFF) published in the Journal of Parkinson's Disease highlights baseline findings from the first three years of operating Fox Trial Finder (www.foxtrialfinder.org). MJFF analyzed data as of July 2014 from registrants (26,231) and studies (329 at 627 sites) with a location in the Unit...Read More